Skip to main content

Scangos George A

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Scangos George A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

VIR Vir Biotechnology, Inc.

Director7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 22, 2022 (view filing)Feb 17-185 daysScangos George APresident and CEOSSale−27.8K$31.11−$863.4K−19.7%113.0K after2 lots
Feb 21, 2023 (view filing)Feb 17-214 daysScangos George APresident and CEOSSale−27.8K$27.23−$755.6K−12.4%196.2K after3 lots
Feb 24, 2023 (view filing)Feb 23-241 dayScangos George APresident and CEOSSale−27.8K$24.53−$680.8K−14.1%168.5K after3 lots
Feb 20, 2024 (view filing)Feb 16-204 daysScangos George ADirectorSSale−27.8K$10.23−$283.8K−16.5%140.7K after2 lots10b5-1
Feb 26, 2024 (view filing)Feb 22-264 daysScangos George ADirectorSSale−27.8K$11.07−$307.2K−19.7%113.0K after2 lots10b5-1
Feb 19, 2025 (view filing)Feb 181 dayScangos George ADirectorSSale−11.0K$9.81−$107.6K−1.5%708.3K after10b5-1
Feb 25, 2025 (view filing)Feb 241 dayScangos George ADirectorSSale−10.1K$9.45−$95.0K−1.4%698.2K after10b5-1